Location: North Carolina, USA.
Department affected: Gardasil Production.
Based on news reporting.
Merck & Co. is set to lay off over 150 employees as it winds down production of its Gardasil vaccine at its North Carolina facility. This decision comes as part of a strategic shift in the company's operations, although specific reasons for the production halt were not detailed in the article. The layoffs will affect workers directly involved in the Gardasil production line, marking a significant change in the company's workforce dynamics in the region. Merck's restructuring efforts reflect broader trends in the pharmaceutical industry, but the focus remains on the impact on its North Carolina operations.
Merck & Co., Inc. cut 150 jobs affecting its Gardasil Production team as of February 27, 2026.
That is roughly 0.2% of the 70,000 people Merck & Co., Inc. employs.
LayoffTalk has tracked 40 layoff events at Merck & Co., Inc. since October 2023, affecting a combined 14,671 employees.
Anonymous by default. Be kind — people reading this may be going through it right now.
Merck & Co., Inc. cut 150 jobs on February 27, 2026. Were you affected, or do you know people who were? How was it handled — severance, notice, which teams? You can post anonymously below.
Share your story anonymously — it helps others reading this feel less alone.
Share your story →Recent tracked events at this company.